Elucigene CF30v2 is a gel based assay that has been developed and approved for routine use in the French national neonatal cystic fibrosis screening program. Detects the thirty most frequent mutations within the French population. Elucigene CF30v2 is also relevant for screening other European populations, particularly those of Spanish and Scandinavian descent.
Instructions for use
KIT, Eluci, CF30v2, 25 T, IVD-CE
4 PCR tubes per sample, 29 mutations detected, Gel based platform